238 related articles for article (PubMed ID: 31181620)
1. Collagen 1A1 (COL1A1) Is a Reliable Biomarker and Putative Therapeutic Target for Hepatocellular Carcinogenesis and Metastasis.
Ma HP; Chang HL; Bamodu OA; Yadav VK; Huang TY; Wu ATH; Yeh CT; Tsai SH; Lee WH
Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31181620
[TBL] [Abstract][Full Text] [Related]
2. Identification of biomarkers associated with partial epithelial to mesenchymal transition in the secretome of slug over-expressing hepatocellular carcinoma cells.
Karaosmanoğlu O; Banerjee S; Sivas H
Cell Oncol (Dordr); 2018 Aug; 41(4):439-453. PubMed ID: 29858962
[TBL] [Abstract][Full Text] [Related]
3. ZnAs@SiO
Huang Y; Zhou B; Luo H; Mao J; Huang Y; Zhang K; Mei C; Yan Y; Jin H; Gao J; Su Z; Pang P; Li D; Shan H
Theranostics; 2019; 9(15):4391-4408. PubMed ID: 31285768
[No Abstract] [Full Text] [Related]
4. AP-2β inhibits hepatocellular carcinoma invasion and metastasis through Slug and Snail to suppress epithelial-mesenchymal transition.
Yang L; Qiu J; Xiao Y; Hu X; Liu Q; Chen L; Huang W; Li X; Li L; Zhang J; Ding X; Xiang S
Theranostics; 2018; 8(13):3707-3721. PubMed ID: 30026878
[TBL] [Abstract][Full Text] [Related]
5. Potential role of microRNA‑223‑3p in the tumorigenesis of hepatocellular carcinoma: A comprehensive study based on data mining and bioinformatics.
Zhang R; Zhang LJ; Yang ML; Huang LS; Chen G; Feng ZB
Mol Med Rep; 2018 Feb; 17(2):2211-2228. PubMed ID: 29207133
[TBL] [Abstract][Full Text] [Related]
6. Identification of COL1A1 and COL1A2 as candidate prognostic factors in gastric cancer.
Li J; Ding Y; Li A
World J Surg Oncol; 2016 Nov; 14(1):297. PubMed ID: 27894325
[TBL] [Abstract][Full Text] [Related]
7. Collagen 1A1 (COL1A1) and Collagen11A1(COL11A1) as diagnostic biomarkers in Breast, colorectal and gastric cancers.
Salimian N; Peymani M; Ghaedi K; Hashemi M; Rahimi E
Gene; 2024 Jan; 892():147867. PubMed ID: 37783295
[TBL] [Abstract][Full Text] [Related]
8. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma.
Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H
J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875
[TBL] [Abstract][Full Text] [Related]
9. RAB18 promotes proliferation and metastasis in hepatocellular carcinoma.
Gong T; Zhou B; Liu M; Chen X; Huang S; Xu Y; Luo R; Chen Z
Am J Transl Res; 2019; 11(2):1009-1019. PubMed ID: 30899400
[TBL] [Abstract][Full Text] [Related]
10. ZIC5 promotes human hepatocellular carcinoma cell proliferation through upregulating COL1A1.
Song W; Yu W; Li D; Cheng C; Wu X; Chen J; Zhang W
J Gastrointest Oncol; 2022 Jun; 13(3):1237-1247. PubMed ID: 35837163
[TBL] [Abstract][Full Text] [Related]
11. Utility of miR‑133a‑3p as a diagnostic indicator for hepatocellular carcinoma: An investigation combined with GEO, TCGA, meta‑analysis and bioinformatics.
Liang HW; Yang X; Wen DY; Gao L; Zhang XY; Ye ZH; Luo J; Li ZY; He Y; Pang YY; Chen G
Mol Med Rep; 2018 Jan; 17(1):1469-1484. PubMed ID: 29138825
[TBL] [Abstract][Full Text] [Related]
12. microRNA-23b suppresses epithelial-mesenchymal transition (EMT) and metastasis in hepatocellular carcinoma via targeting Pyk2.
Cao J; Liu J; Long J; Fu J; Huang L; Li J; Liu C; Zhang X; Yan Y
Biomed Pharmacother; 2017 May; 89():642-650. PubMed ID: 28262617
[TBL] [Abstract][Full Text] [Related]
13. A Preliminary Investigation of PVT1 on the Effect and Mechanisms of Hepatocellular Carcinoma: Evidence from Clinical Data, a Meta-Analysis of 840 Cases, and In Vivo Validation.
Zhang Y; Wen DY; Zhang R; Huang JC; Lin P; Ren FH; Wang X; He Y; Yang H; Chen G; Luo DZ
Cell Physiol Biochem; 2018; 47(6):2216-2232. PubMed ID: 29975928
[TBL] [Abstract][Full Text] [Related]
14. Collagen 1A1 (COL1A1) promotes metastasis of breast cancer and is a potential therapeutic target.
Liu J; Shen JX; Wu HT; Li XL; Wen XF; Du CW; Zhang GJ
Discov Med; 2018 May; 25(139):211-223. PubMed ID: 29906404
[TBL] [Abstract][Full Text] [Related]
15. HBX-induced miR-5188 impairs FOXO1 to stimulate β-catenin nuclear translocation and promotes tumor stemness in hepatocellular carcinoma.
Lin X; Zuo S; Luo R; Li Y; Yu G; Zou Y; Zhou Y; Liu Z; Liu Y; Hu Y; Xie Y; Fang W; Liu Z
Theranostics; 2019; 9(25):7583-7598. PubMed ID: 31695788
[TBL] [Abstract][Full Text] [Related]
16. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
[TBL] [Abstract][Full Text] [Related]
17. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
18. Lymphoid Enhancer Factor 1 Contributes to Hepatocellular Carcinoma Progression Through Transcriptional Regulation of Epithelial-Mesenchymal Transition Regulators and Stemness Genes.
Chen CL; Tsai YS; Huang YH; Liang YJ; Sun YY; Su CW; Chau GY; Yeh YC; Chang YS; Hu JT; Wu JC
Hepatol Commun; 2018 Nov; 2(11):1392-1407. PubMed ID: 30411085
[TBL] [Abstract][Full Text] [Related]
19. Intergrated analysis of ELMO1, serves as a link between tumour mutation burden and epithelial-mesenchymal transition in hepatocellular carcinoma.
Peng H; Zhang Y; Zhou Z; Guo Y; Huang X; Westover KD; Zhang Z; Chen B; Hua Y; Li S; Xu R; Lin N; Peng B; Shen S
EBioMedicine; 2019 Aug; 46():105-118. PubMed ID: 31324602
[TBL] [Abstract][Full Text] [Related]
20. SSR2 overexpression associates with tumorigenesis and metastasis of Hepatocellular Carcinoma through modulating EMT.
Hong X; Luo H; Zhu G; Guan X; Jia Y; Yu H; Lv X; Yu T; Lan H; Zhang Q; Li H; Sun W; Huang X; Li J
J Cancer; 2020; 11(19):5578-5587. PubMed ID: 32913453
[No Abstract] [Full Text] [Related]
[Next] [New Search]
